503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
0.81%
Revenue growth below 50% of PLTR's 13.56%. Michael Burry would check for competitive disadvantage risks.
90.99%
Cost growth above 1.5x PLTR's 11.54%. Michael Burry would check for structural cost disadvantages.
-13.92%
Gross profit decline while PLTR shows 14.05% growth. Joel Greenblatt would examine competitive position.
-14.61%
Margin decline while PLTR shows 0.43% expansion. Joel Greenblatt would examine competitive position.
27.60%
R&D growth above 1.5x PLTR's 0.11%. Michael Burry would check for spending discipline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.71%
Operating expenses reduction while PLTR shows 1.24% growth. Joel Greenblatt would examine advantage.
8.78%
Total costs growth above 1.5x PLTR's 3.75%. Michael Burry would check for inefficiency.
No Data
No Data available this quarter, please select a different quarter.
16.77%
D&A growth while PLTR reduces D&A. John Neff would investigate differences.
-4.77%
EBITDA decline while PLTR shows 81.84% growth. Joel Greenblatt would examine position.
93.10%
EBITDA margin growth exceeding 1.5x PLTR's 60.13%. David Dodd would verify competitive advantages.
-8.24%
Operating income decline while PLTR shows 52.98% growth. Joel Greenblatt would examine position.
-8.98%
Operating margin decline while PLTR shows 34.71% growth. Joel Greenblatt would examine position.
-501.97%
Other expenses reduction while PLTR shows 32.97% growth. Joel Greenblatt would examine advantage.
-97.32%
Pre-tax income decline while PLTR shows 48.74% growth. Joel Greenblatt would examine position.
-97.34%
Pre-tax margin decline while PLTR shows 30.98% growth. Joel Greenblatt would examine position.
-97.27%
Both companies reducing tax expense. Martin Whitman would check patterns.
-97.35%
Net income decline while PLTR shows 52.65% growth. Joel Greenblatt would examine position.
-97.37%
Net margin decline while PLTR shows 34.43% growth. Joel Greenblatt would examine position.
-97.83%
EPS decline while PLTR shows 55.56% growth. Joel Greenblatt would examine position.
-97.73%
Diluted EPS decline while PLTR shows 62.50% growth. Joel Greenblatt would examine position.
0.82%
Share count reduction below 50% of PLTR's 0.70%. Michael Burry would check for concerns.
0.14%
Diluted share reduction exceeding 1.5x PLTR's 0.40%. David Dodd would verify capital allocation.